A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study
Yusuke Chihara, Takayuki Takeda, Yasuhiro Goto, Yoichi Nakamura, Yuko Tsuchiya-Kawano, Akira Nakao, Keisuke Onoi, Makoto Hibino, Minoru Fukuda, Ryoichi Honda, Takahiro Yamada, Ryusuke Taniguchi, Sinjiro Sakamoto, Koji Date, Seiji Nagashima, Shigeru Tanzawa, Koichi Minato, Koichi Nakatani, Miiru Izumi, Takayuki Shimose
- Uji-Tokushukai Medical Center
- Japanese Red Cross Kyoto Daini Hospital
- Fujita Health University
- Tochigi Cancer Center
- Kitakyushu Municipal Medical Center
- Fukuoka University
- Kyoto Prefectural University of Medicine
- Shonan Fujisawa Tokushukai Hospital
- Nagasaki University
- Asahi General Hospital
- Matsushita Memorial Hospital
- Otsu City Hospital
- Hiroshima University
- Kyoto Chubu Medical Center
- National Hospital Organization Nagasaki Medical Center
- Gunma Prefectural Cancer Center
- National Hospital Organization Kyoto Medical Center
- National Hospital Organization Omuta National Hospital
- Clinical Research Support Center Kyushu
- Kyushu University
研究成果: ジャーナルへの寄稿 › 記事 › 査読
11
被引用数
(Scopus)